"From Lab to Production: Industrial-Scale 98% IcariinExtraction Technology & Critical Quality Control Parameters"
Title:
"From Lab to Production: Industrial-Scale 98% IcariinExtraction Technology & Critical Quality Control Parameters"
Meta Description:
Blue Eyes Biotech reveals breakthrough technology forconsistent ≥98% icariinproduction at commercial scale. Download our quality control whitepaper withfull HPLC methodologies.
Industrial Advancements in IcariinStandardization
Blue Eyes Biotech CO., Ltd. has perfected ascalable extraction process delivering pharmaceutical-grade icariin withunmatched consistency:
Core Technology Innovations:
• Dual-phasesolvent system achieves 98.2±0.8% purity (HPLC-UV)
• Continuouscentrifugal chromatography reduces processing time by 65%
• AI-poweredreal-time monitoring ensures batch-to-batch consistency
Quality Control Milestones:
→ Residualsolvent <10ppm (meets ICH Q3C guidelines)
→ Heavy metals<0.5ppm (ICP-MS verified)
→ Microbiallimits exceeding USP <61> requirements
Production Advantages:
✔ 500kg/month capacity currentlyavailable
✔ 45% higher yield vs conventional ethanolextraction
✔ Solvent recovery rate >92% forsustainable production
"Our process controls 17 criticalparameters simultaneously - a first for botanical extracts," states Dr.Liang Wei, VP of Manufacturing.
For Commercial Buyers:
• Available asIcariPure™-98 (minimum 98% icariin)
• Customizablespecifications:
-Particle size (80-300 mesh)
-Bulk density (0.25-0.45g/cm³)
-Solubility profiles
• Completedocumentation:
-Method validation reports
-36-month stability data
-FDA DMF available
Request Technical Dossier & ProductionAudit:
